Data gathered: September 13
Alternative Data for Conduit Pharmaceuticals
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | N/A | Sign up | Sign up | Sign up |
| Sentiment | 50 | Sign up | Sign up | Sign up |
| Webpage traffic | 2,000 | Sign up | Sign up | Sign up |
| Google Trends | 11 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 24 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 1,240 | Sign up | Sign up | Sign up |
| Twitter Mentions | 39 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Linkedin Employees | 4 | Sign up | Sign up | Sign up |
About Conduit Pharmaceuticals
Conduit Pharmaceuticals Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility.
| Price | $0.14 |
| Target Price | Sign up |
| Volume | 1,360,000 |
| Market Cap | $14M |
| Year Range | $0.12 - $5.19 |
| Dividend Yield | 0% |
| Industry | Biotechnology |
In the news
 |
Conduit Pharmaceuticals files to sell 22M shares of common stock for holdersSeptember 4 - Thefly.com |
 |
Short Interest in Conduit Pharmaceuticals Inc. (NASDAQ:CDT) Rises By 386.4%August 29 - ETF Daily News |
 |
Conduit Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceAugust 27 - Yahoo |
 |
Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW) Short Interest Down 11.4% in JulyAugust 19 - ETF Daily News |
 |
Why Is Conduit Pharmaceuticals (CDT) Stock Up 12% Today?August 14 - Biztoc.com |
 |
CDT Stock Earnings: Conduit Pharmaceuticals Reported Results for Q2 2024August 13 - Biztoc.com |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q2 '24 | 604M | 3.1M | -3.1M | -5.4M | -3.1M | -0.073 |
| Q1 '24 | 536M | 2.8M | -2.8M | -3.6M | -3M | -0.048 |
| Q4 '23 | 0 | 810,000 | -1.1M | 280,000 | 2.1M | -0.015 |
| Q3 '23 | 150,000 | 1.1M | -920,000 | 2.6M | 2M | -0.003 |
| Q2 '23 | 18,000 | 380,000 | -380,000 | -2.1M | -1.7M | -0.055 |
Insider Transactions View All
| Tapolczay David filed to sell 200,332 shares at $0. April 24 '24 |
| Farley Chele Chiavacci filed to buy 203,332 shares at $0. April 24 '24 |
Similar companies
Read more about Conduit Pharmaceuticals (CDT) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter mentions, news mentions, customer reviews & linkedin employees.
What is the Market Cap of Conduit Pharmaceuticals?
The Market Cap of Conduit Pharmaceuticals is $14M.
What is the current stock price of Conduit Pharmaceuticals?
Currently, the price of one share of Conduit Pharmaceuticals stock is $0.14.
How can I analyze the CDT stock price chart for investment decisions?
The CDT stock price chart above provides a comprehensive visual representation of Conduit Pharmaceuticals' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Conduit Pharmaceuticals shares. Our platform offers an up-to-date CDT stock price chart, along with technical data analysis and alternative data insights.
Does CDT offer dividends to its shareholders?
As of our latest update, Conduit Pharmaceuticals (CDT) does not offer dividends to its shareholders. Investors interested in Conduit Pharmaceuticals should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Conduit Pharmaceuticals?
Some of the similar stocks of Conduit Pharmaceuticals are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.